Customized gene production with plasmid preparation [22-009057]
Ended Awarded
- Contract number
- 75N94022F00001
- Awardee
-
Genscript USA Inc. UEI KVLBRRAQ6UX1
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,500
Award facts
- Contract value 100% obligated
- $24,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621991 Blood and Organ Banks
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Piscataway, NJ 08854, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Child Health and Human Development awarded a $24,500 firm fixed price contract to Genscript USA Inc. for customized gene production with plasmid preparation services. This contract was awarded on June 23, 2022, under a Blanket Purchase Agreement (BPA) call mechanism, with an ultimate completion date of June 22, 2023. The work will be performed at Genscript's facility in Piscataway, New Jersey. No small business set-aside designation was applied to this award.
Genscript USA Inc. is a biotechnology company specializing in advanced molecular biology services for federal research institutions. The company provides gene synthesis, plasmid preparation, and custom biological research materials that support federal agencies' scientific and public health research initiatives. As an established vendor in the federal marketplace since 2013, Genscript maintains significant contract relationships with multiple federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and the Food and Drug Administration, demonstrating its capability to deliver specialized molecular biology support for biomedical research applications.
Quick answers
Who was awarded contract 75N94022F00001?
75N94022F00001 was awarded to Genscript USA Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on June 23, 2022.
How much is contract 75N94022F00001 worth?
The government has obligated $24,500 on 75N94022F00001.
Is contract 75N94022F00001 an order under another contract?
Yes. 75N94022F00001 is a BPA call under HHSN263201400039B, a blanket purchase agreement.
Was contract 75N94022F00001 competed?
The extent of competition for 75N94022F00001 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award